Web Analytics

3 Latest Announced Rounds

  • $55,000,000
    Seed

    2 Investors

    Financial Services
    Dec 18th, 2024
  • $1,300,000
    Unknown

    2 Investors

    Software Development
    Dec 18th, 2024
  • $11,500,000
    Series A

    6 Investors

    Embedded Software Products
    Dec 18th, 2024
$883.20M Raised in 47 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Pleno Inc.

start up
United States - San Diego, California
  • 13/12/2024
  • Series B
  • $25,000,000

Pleno Inc. is an early-stage San Diego startup company developing a multi-omic instrument platform to revolutionize biological target detection for clinical testing and biomedical research and enable a broad array of applications from screening and detection, to diagnostics, prognostics and beyond.

We are driven and dedicated scientists, engineers and business professionals. We’re developing an innovative and disruptive multi-omic instrument platform that’s going to transform the insights from and application of biological information. We’re in an exciting growth phase and are actively expanding our team.

Join us to experience the energy and excitement of taking on the biggest challenges in biosciences and biotechnology to develop innovative solutions that will disrupt the industry. You’ll have the support to flourish both professionally and personally, where your ideas are valued and your commitment and collaboration is key to our success.


Related People

Vik Vaz, M.D.Founder

Vik Vaz, M.D. United States - San Diego, California

Global executive with a mix of strategy, commercial, and clinical experience across the health care value chain, creating significant value for patients and organizations. Expert in deal sourcing, structuring, and execution with a record of building top performing teams under challenging circumstances. Combines expertise in clinical and biopharma market development and strategy along with competitive intelligence.

Successfully grew a Pharma/Companion diagnostic business and oversaw the enterprise-wide strategy and portfolio investment for Illumina, the global leader in clinical genomics. Former McKinsey & BCG Partner leading growth strategy projects for top Pharmaceutical & Med Tech companies.